Microbot Medical, Inc. Common Stock (MBOT) is a publicly traded Healthcare sector company. As of July 7, 2026, MBOT trades at $1.89 with a market cap of $128.28M and a P/E ratio of -6.71. MBOT moved -3.11% today. Year to date, MBOT is -5.85%; over the trailing twelve months it is -25.77%. Its 52-week range spans $0.89 to $4.67. Analyst consensus is strong buy with an average price target of $7.17. Rallies surfaces MBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover MBOT: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.17.
| Metric | Value |
|---|---|
| Price | $1.89 |
| Market Cap | $128.28M |
| P/E Ratio | -6.71 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.67 |
| 52-Week Low | $0.89 |
| Volume | 680.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.14M |
| Gross Margin | 0.00% |
3 analysts cover MBOT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.17.